AGP Picks
View all

The Boston Examiner
Provided by AGP

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 5, 2026

Editas Medicine Announces Second Quarter 2026 Results and Business Updates
Aug. 5, 2026

Editas Medicine Announces Second Quarter 2026 Results and Business Updates

Indeterminate GlobeNewswire
Symbotic Reports Third Quarter Fiscal Year 2026 Results
Aug. 5, 2026

Symbotic Reports Third Quarter Fiscal Year 2026 Results

Indeterminate GlobeNewswire
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
Aug. 5, 2026

Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026

Indeterminate GlobeNewswire
Apptopia: Kalshi May Be Good for OSBs
Aug. 5, 2026

Apptopia: Kalshi May Be Good for OSBs

Indeterminate GlobeNewswire
Destination Stewardship Author Tonya Fitzpatrick to Discuss Tourism and Community Life at Oak Bluffs Public Library
Aug. 5, 2026

Destination Stewardship Author Tonya Fitzpatrick to Discuss Tourism and Community Life at Oak Bluffs Public Library

Indeterminate EIN Presswire
Rocket Software Named a Challenger in the 2026 Gartner® Magic Quadrant™ for AI-Augmented Code Modernization Tools
Aug. 5, 2026

Rocket Software Named a Challenger in the 2026 Gartner® Magic Quadrant™ for AI-Augmented Code Modernization Tools

Indeterminate GlobeNewswire
Plastics in Electronics Components Market to Reach $23.6 Billion by 2031, Driven by AI Hardware and Data Center Expansion
Aug. 5, 2026

Plastics in Electronics Components Market to Reach $23.6 Billion by 2031, Driven by AI Hardware and Data Center Expansion

Indeterminate GlobeNewswire
Heilind Electronics Adds Switchcraft Conxall Multi-Con-X® Mixed Signal/Power Connectors
Aug. 5, 2026

Heilind Electronics Adds Switchcraft Conxall Multi-Con-X® Mixed Signal/Power Connectors

Indeterminate GlobeNewswire
Tive Helps Venture Metals+ Prevent More Than $1 Million in Cargo Theft Losses in the First Half of 2026
Aug. 5, 2026

Tive Helps Venture Metals+ Prevent More Than $1 Million in Cargo Theft Losses in the First Half of 2026

Indeterminate GlobeNewswire
PaymentWorks Launches Payee Profile to Make Vendor Identity Portable Across B2B Payments
Aug. 5, 2026

PaymentWorks Launches Payee Profile to Make Vendor Identity Portable Across B2B Payments

Indeterminate GlobeNewswire
Ascend Learning Acquires TAMS to Strengthen Faculty Operations at Nursing Schools
Aug. 5, 2026

Ascend Learning Acquires TAMS to Strengthen Faculty Operations at Nursing Schools

Indeterminate GlobeNewswire
Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study
Aug. 5, 2026

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Indeterminate GlobeNewswire
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
Aug. 5, 2026

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Indeterminate GlobeNewswire
ImageneBio Reports Second Quarter 2026 Financial Results
Aug. 5, 2026

ImageneBio Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis
Aug. 5, 2026

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Indeterminate GlobeNewswire
Robinson Unmanned Invited to Participate in Drone Dominance Program Gauntlet II, Continues Phase One Deliveries
Aug. 5, 2026

Robinson Unmanned Invited to Participate in Drone Dominance Program Gauntlet II, Continues Phase One Deliveries

Indeterminate GlobeNewswire
CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference
Aug. 5, 2026

CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire
Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug. 5, 2026

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
Aug. 5, 2026

Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire
Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026
Aug. 5, 2026

Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.